Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 30 $ 226,041 $ (220,629) $ 5,442
Balance, shares at Dec. 31, 2017 3,028,065      
Issuance of common stock from the exercise of warrants $ 7 1,321 1,328
Issuance of common stock from the exercise of warrants, shares 668,335      
Issuance of common stock in exchange for reduction in debt $ 6 1,447 1,453
Issuance of common stock in exchange for reduction in debt, shares 580,444      
Loss on extinguishment of derivative liability 1,040 1,040
Warrants issued in association with debt 98 98
Deemed dividend related to adjustment of the exercise price of warrants issued with debt (9) (9)
Accretion of change in warrant exercise price 9 9
Stock-based compensation 24 24
Net loss (3,399) (3,399)
Balance at Mar. 31, 2018 $ 43 229,971 (224,028) 5,986
Balance, shares at Mar. 31, 2018 4,276,844      
Balance at Dec. 31, 2018 $ 218 237,462 (229,281) 8,399
Balance, shares at Dec. 31, 2018 4,074 21,793,641      
Issuance of common stock in exchange for reduction in debt        
Net loss (1,629) (1,629)
Balance at Mar. 31, 2019 $ 218 $ 237,462 $ (230,910) $ 6,770
Balance, shares at Mar. 31, 2019 4,074 21,793,641